NCT07053748View on ClinicalTrials.gov

Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
High - Risk NMIBC
Interventions
RADIATION

Trimodality Bladder-preserving Therapy

High-risk NMIBC patients who have a strong desire to preserve their bladder actively choose to receive Trimodality Bladder-preserving Therapy instead of radical resection.

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT07053748 - Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy | Biotech Hunter | Biotech Hunter